Protara Therapeutics
(NASDAQ) TARA
Protara Therapeutics Financials at a Glance
Market Cap
$287.19M
Revenue (TTM)
$0.00
Net Income (TTM)
$57.44M
EPS (TTM)
$-1.34
P/E Ratio
-3.97
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Price
$4.95
Volume
24,844
Open
$5.25
Price
$4.95
Volume
24,844
Open
$5.25
Previous Close
$5.31
Daily Range
$4.93 - $5.25
52-Week Range
$2.77 - $7.82
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Price
$4.95
Volume
24,844
Open
$5.25
Previous Close
$5.31
Daily Range
$4.93 - $5.25
52-Week Range
$2.77 - $7.82
TARA News
TARA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Protara Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
51
CEO
Jesse Shefferman, MBA
Website
www.protaratx.comHeadquarters
New York City, NY 10010, US
TARA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-32%
Return on Capital
-33%
Return on Assets
-27%
Earnings Yield
-25.19%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$287.19M
Shares Outstanding
54.08M
Volume
24.84K
Short Interest
0.00%
Avg. Volume
1.08M
Financials (TTM)
Gross Profit
$362.00K
Operating Income
$64.55M
EBITDA
$64.19M
Operating Cash Flow
$56.37M
Capital Expenditure
$94.00K
Free Cash Flow
$56.46M
Cash & ST Invst.
$155.55M
Total Debt
$3.36M
Protara Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$93.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$287.19M
N/A
Market Cap/Employee
$10.26M
N/A
Employees
28
N/A
Net Income
$17.31M
-35.5%
EBITDA
$19.08M
-34.1%
Quarterly Fundamentals
Net Cash
$152.19M
-8.2%
Accounts Receivable
$1.26M
N/A
Inventory
$0.00
N/A
Long Term Debt
$2.12M
-37.0%
Short Term Debt
$1.24M
+10.5%
Return on Assets
-27.42%
N/A
Return on Invested Capital
-32.51%
N/A
Free Cash Flow
$16.97M
-82.4%
Operating Cash Flow
$16.95M
-82.1%